{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:30:52Z","timestamp":1769099452841,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/md.0000000000012355","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T08:43:45Z","timestamp":1538210625000},"page":"e12355","source":"Crossref","is-referenced-by-count":10,"title":["A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis"],"prefix":"10.1097","volume":"97","author":[{"given":"Antonio G.","family":"Solimando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azzurra","family":"Sportelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Troiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Demarinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Serio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Ostuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-35-20210309","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R2-35-20210309","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/10428194.2012.671481","article-title":"Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature","volume":"54","author":"Payet","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R3-35-20210309","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine (Baltimore"},{"key":"R4-35-20210309","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"R5-35-20210309","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/asheducation-2005.1.368","article-title":"ASH Education Book","volume":"2005","author":"Morra","year":"2005","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R6-35-20210309","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias","volume":"88","author":"Monti","year":"1995","journal-title":"QJM"},{"key":"R7-35-20210309","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","article-title":"Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center","volume":"80","author":"Trejo","year":"2001","journal-title":"Medicine (Baltimore"},{"key":"R8-35-20210309","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/bjh.13196","article-title":"Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases","volume":"168","author":"Harel","year":"2015","journal-title":"Br J Haematol"},{"key":"R9-35-20210309","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"},{"key":"R10-35-20210309","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejim.2017.04.001","article-title":"Clinical disorders responsible for plasma hyperviscosity and skin complications","volume":"42","author":"Caimi","year":"2017","journal-title":"Eur J Intern Med"},{"key":"R11-35-20210309","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ajh.24402","article-title":"Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Am J Hematol"},{"key":"R12-35-20210309","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11926-003-0038-0","article-title":"Pulmonary-renal vasculitic disorders: differential diagnosis and management","volume":"5","author":"Jara","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"R13-35-20210309","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"R14-35-20210309","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"R15-35-20210309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"R16-35-20210309","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome\u2014biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R17-35-20210309","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"R18-35-20210309","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R19-35-20210309","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/156652413804486304","article-title":"Tumor-derived microvesicles and the cancer microenvironment","volume":"13","author":"Camussi","year":"2013","journal-title":"Curr Mol Med"},{"key":"R20-35-20210309","first-page":"842849","article-title":"The roles of tumor-derived exosomes in cancer pathogenesis","volume":"2011","author":"Yang","year":"2011","journal-title":"Clin Devel Immunol"},{"key":"R21-35-20210309","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"key":"R22-35-20210309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2016-09-719773","article-title":"How I treat cryoglobulinemia","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"R23-35-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jbspin.2017.06.001","article-title":"Apheresis to treat systemic vasculitis","volume":"85","author":"Moussi-Frances","year":"2018","journal-title":"Joint Bone Spine"},{"key":"R24-35-20210309","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2015-01-553974","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"126","author":"Treon","year":"2015","journal-title":"Blood"},{"key":"R25-35-20210309","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2007.08143.x","article-title":"Therapeutic effect of lipoprostaglandin E1 on livedoid vasculitis associated with essential cryoglobulinaemia","volume":"157","author":"Kawakami","year":"2007","journal-title":"Br J Dermatol"},{"key":"R26-35-20210309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.transci.2018.02.014","article-title":"The use of emergency apheresis in the management of plasma cell disorders","volume":"57","author":"Kalayoglu-Besisik","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"R27-35-20210309","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.critrevonc.2017.11.016","article-title":"A question of class: treatment options for patients with relapsed and\/or refractory multiple myeloma","volume":"121","author":"Cook","year":"2018","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000012355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:28:15Z","timestamp":1620962895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201809280-00035"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":27,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012355","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}